Mills H J, Horne G, Devane P
Department of Surgery, Wellington School of Medicine.
N Z Med J. 1995 Nov 10;108(1011):458-9.
To examine the incidence, and results of treatment of osteosarcoma in New Zealand between 1981 and 1987.
Data was obtained from the Cancer Registry for all patients registered with osteosarcoma between 1981 and 1987.
There were 104 patients in the study group. There was a peak incidence in the second decade with a second smaller peak in the seventh and eight decades. The overall 5 year survival rate was 29%. For the group aged under 30 years there was a 44% 5 year survival rate. Those aged over 60 years had a 3.2% 5 year survival. Survival rates were better when treated with surgery and chemotherapy and where the tumour was of the appendicular skeleton.
This is a mixed group of patients. The 5 year survival rates appear to be at the lower end of the spectrum of the results reported for similar groups in other countries.
研究1981年至1987年间新西兰骨肉瘤的发病率及治疗结果。
从癌症登记处获取1981年至1987年间所有登记为骨肉瘤患者的数据。
研究组有104名患者。发病率在第二个十年出现高峰，在第七和第八个十年出现第二个较小高峰。总体5年生存率为29%。30岁以下组的5年生存率为44%。60岁以上者的5年生存率为3.2%。采用手术和化疗治疗以及肿瘤位于四肢骨骼时生存率更高。
这是一组混合患者。5年生存率似乎处于其他国家类似组报告结果范围的较低端。
